FLCN and neoplasm: Precisely how loss-of-function mutations in FLCN lead to tumor development requires further investigation, although it is possible that cells attempt to compensate for the reduction in FLCN-mediated mTORC1 activation by amplifying the activity of other mTORC1 activators or growth-promoting pathways [27].